JP2000514402A5 - - Google Patents

Download PDF

Info

Publication number
JP2000514402A5
JP2000514402A5 JP1997539298A JP53929897A JP2000514402A5 JP 2000514402 A5 JP2000514402 A5 JP 2000514402A5 JP 1997539298 A JP1997539298 A JP 1997539298A JP 53929897 A JP53929897 A JP 53929897A JP 2000514402 A5 JP2000514402 A5 JP 2000514402A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997539298A
Other languages
English (en)
Other versions
JP2000514402A (ja
JP4122060B2 (ja
Filing date
Publication date
Priority claimed from US08/841,739 external-priority patent/US6114320A/en
Application filed filed Critical
Publication of JP2000514402A publication Critical patent/JP2000514402A/ja
Publication of JP2000514402A5 publication Critical patent/JP2000514402A5/ja
Application granted granted Critical
Publication of JP4122060B2 publication Critical patent/JP4122060B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2000514402
Figure 2000514402
Figure 2000514402
Figure 2000514402
Figure 2000514402
JP53929897A 1996-05-01 1997-05-01 Vegfに関連する目の病気に関する治療処置 Expired - Fee Related JP4122060B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1665896P 1996-05-01 1996-05-01
US60/016,658 1996-05-01
US08/841,739 1997-04-30
US08/841,739 US6114320A (en) 1996-05-01 1997-04-30 Therapeutic treatment for VEGF related ocular diseases
PCT/US1997/007800 WO1997040831A1 (en) 1996-05-01 1997-05-01 Therapeutic treatment for vegf related occular diseases

Publications (3)

Publication Number Publication Date
JP2000514402A JP2000514402A (ja) 2000-10-31
JP2000514402A5 true JP2000514402A5 (ja) 2006-03-23
JP4122060B2 JP4122060B2 (ja) 2008-07-23

Family

ID=26688915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53929897A Expired - Fee Related JP4122060B2 (ja) 1996-05-01 1997-05-01 Vegfに関連する目の病気に関する治療処置

Country Status (22)

Country Link
US (1) US6114320A (ja)
EP (1) EP0918519B1 (ja)
JP (1) JP4122060B2 (ja)
KR (1) KR100364487B1 (ja)
CN (1) CN1158073C (ja)
AT (1) ATE270548T1 (ja)
AU (1) AU724923B2 (ja)
BR (1) BR9710705A (ja)
CA (1) CA2253613C (ja)
CZ (1) CZ296711B6 (ja)
DE (1) DE69729798T2 (ja)
EA (1) EA001752B1 (ja)
ES (1) ES2224249T3 (ja)
HK (1) HK1020017A1 (ja)
HU (1) HU226378B1 (ja)
IL (1) IL126836A (ja)
NO (1) NO322209B1 (ja)
NZ (2) NZ538109A (ja)
PL (1) PL189020B1 (ja)
PT (1) PT918519E (ja)
UA (1) UA54427C2 (ja)
WO (1) WO1997040831A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
US6093740A (en) * 1997-04-30 2000-07-25 Eli Lilly And Company Therapeutic treatment for skin disorders
EP1105136B1 (en) * 1998-08-13 2007-08-29 Novartis AG Method for treating ocular neovascular diseases
US6214819B1 (en) 1998-11-23 2001-04-10 Novartis Ag Method for treating ocular neovascular diseases
ES2211197T3 (es) * 1998-11-23 2004-07-01 Novartis Ag Uso de derivados de estaurosporina para tratar enfermedades neovasculares oculares.
DE69926536T3 (de) 1998-12-22 2013-09-12 Genentech, Inc. Antagonisten von vaskular-endothelialen zellwachstumsfaktoren und ihre anwendung
US6271233B1 (en) 1999-08-10 2001-08-07 Ciba Vision Corporation Method for treating ocular neovascular diseases
US6921763B2 (en) 1999-09-17 2005-07-26 Abbott Laboratories Pyrazolopyrimidines as therapeutic agents
IL151045A0 (en) 2000-02-07 2003-04-10 Abbott Gmbh & Co Kg 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
MXPA03008560A (es) 2001-03-22 2004-06-30 Abbot Gmbh & Co Kg Pirazolopirimidinas como agentes terapeuticos.
US20020165158A1 (en) * 2001-03-27 2002-11-07 King George L. Methods of modulating angiogenesis
US20030119812A1 (en) * 2001-11-08 2003-06-26 Brazzell Romulus Kimbro Method for decreasing capillary permeability in the retina
US20030236246A1 (en) * 2002-04-30 2003-12-25 Brazzell Romulus Kimbro Method for decreasing capillary permeability in the retina
EP2319493A3 (en) * 2002-07-23 2011-07-27 Novartis AG Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
US20070059381A1 (en) * 2003-06-20 2007-03-15 Barker Ronnie C Treatment of amd with combination of ingredients
JP2007529434A (ja) * 2004-03-17 2007-10-25 ラース マイケル ラーセン, 視覚サイクルの阻害による網膜症の予防
BRPI0509576A (pt) 2004-04-02 2007-05-29 Osi Pharm Inc composto, método de tratamento de um paciente tendo uma condição que é mediada pela atividade de proteìna quinase, e, composição farmacêutica
TW200613306A (en) 2004-07-20 2006-05-01 Osi Pharm Inc Imidazotriazines as protein kinase inhibitors
AR057960A1 (es) 2005-12-02 2007-12-26 Osi Pharm Inc Inhibidores de proteina quinasa biciclicos
US7455447B2 (en) * 2006-05-19 2008-11-25 Mediatek Inc. Method and apparatus for a portable device
AU2007286817A1 (en) * 2006-08-23 2008-02-28 Novartis Ag Use of PKC inhibitors in particular indolylmaleimide derivatives in ocular diseases
EP2089016A4 (en) * 2006-10-03 2014-10-08 Univ Pennsylvania METHOD FOR TREATING MACULAR AGENCY
US10360673B2 (en) 2015-03-26 2019-07-23 Eyekor, Llc Image analysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
IL111851A (en) * 1993-12-07 1998-09-24 Lilly Co Eli Improved synthesis of bisindolylsimilides and process for its preparation
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
CN1050844C (zh) * 1993-12-07 2000-03-29 伊莱利利公司 蛋白激酶c抑制剂
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2000510961A5 (ja)
JP2000504725A5 (ja)
JP2001503253A5 (ja)
JP2000503844A5 (ja)
JP2000502472A5 (ja)
JP2000501825A5 (ja)
JP2000517216A5 (ja)
JP2000502485A5 (ja)
JP2000516705A5 (ja)
JP2000512342A5 (ja)
JP2000502425A5 (ja)
JP2000501774A5 (ja)
JP2002509587A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2000501876A5 (ja)
JP2000513607A5 (ja)
JP2000501744A5 (ja)
JP2000504045A5 (ja)
JP2000502316A5 (ja)
JP2000502714A5 (ja)
JP2000505297A5 (ja)